Shein prepares to reduce assessment to $30b for London IPO: resources
Shein covertly looked for an IPO in London in June 2023.
Today: Jun 17, 2025
Dark
Light
Suggestions
China’s biopharma market strikes $30b in oncology licensing offers
In 2024, antibody-drug conjugates controlled the licensing project. China’s biopharmaceutical market has actually seen a sharp surge in oncology medication licensing arrangements in 2024, specifically monoclonal antibodies (MABS) and antibody-toxin conjugates (ADCS),